Short description
RVAC Medicines is an mRNA platform company with a pipeline of novel products covering a wide range of disease areas.
Description
RVAC Medicines is an mRNA platform company with a pipeline of novel products covering a wide range of disease areas. The company is building a pipeline of novel mRNA vaccines and therapeutics to address unmet medical needs, particularly in emerging markets. It's cutting-edge GMP manufacturing facilities that will advance its platform technologies through in-house research and development and external partnerships, enabling the production of cutting-edge mRNA and nucleic acid delivery technologies.
RVAC Medicines was founded in 2021 and is based in Singapore.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Singapore, Central Region, Singapore, Asia
Founded on
January 1, 2021
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Uh Ohhhh, Blurry Noaccess, No Way
Sign in for full access